TSX:ONC
Oncolytics Biotech Inc.
- Stock
locale
Canada
market
STOCKSindustry
Biotechnologywebsite
www.oncolyticsbiotech.comipo date
Jun 01, 2000
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Me...Show More
Earnings
Earnings Release in 15 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus